Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ferrari

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|January 20, 2022
High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphomaAnna Ferrari, Silvia Arniani, Barbara Crescenzi, et al.
Leukemia & Lymphoma|September 13, 2017
RALE051: a novel established cell line of sporadic Burkitt lymphomaAlberto L'Abbate, Ilaria Iacobucci, Angelo Lonoce, et al.
Experimental Hematology & Oncology|August 28, 2015
Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphomaEnrico Derenzini, Ilaria Iacobucci, Claudio Agostinelli, et al.
Cancer Research|December 14, 2017
Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph<sup>+</sup> Acute Lymphoblastic LeukemiaMarco De Dominici, Patrizia Porazzi, Angela Rachele Soliera, et al.
Oncotarget|December 30, 2014
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphomaEnrico Derenzini, Claudio Agostinelli, Enrica Imbrogno, et al.
Respiratory Research|April 17, 2026
Quantitative computed tomography body composition analysis for risk stratification in bronchiectasisUmberto Semenzato, Virginia Santello, Giulia Fichera, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 5, 2026
Patient's features, clinical patterns and outcomes of non-tuberculous mycobacteria infections: A 10-year retrospective analysis from a third level university hospitalMaria Mazzitelli, Anna Ferrari, Giacomo Berti, et al.
BMC Bioinformatics|February 11, 2017
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing dataÍtalo Faria do Valle, Enrico Giampieri, Giorgia Simonetti, et al.
Oncotarget|July 21, 2016
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemiaAndrea Ghelli Luserna Di Rorà, Ilaria Iacobucci, Enrica Imbrogno, et al.
British Journal of Haematology|December 14, 2020
Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemiaAnna Ferrari, Andrea Ghelli Luserna Di Rora, Chiara Domizio, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|January 20, 2022
High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphomaAnna Ferrari, Silvia Arniani, Barbara Crescenzi, et al.
Leukemia & Lymphoma|September 13, 2017
RALE051: a novel established cell line of sporadic Burkitt lymphomaAlberto L'Abbate, Ilaria Iacobucci, Angelo Lonoce, et al.
Experimental Hematology & Oncology|August 28, 2015
Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphomaEnrico Derenzini, Ilaria Iacobucci, Claudio Agostinelli, et al.
Cancer Research|December 14, 2017
Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph<sup>+</sup> Acute Lymphoblastic LeukemiaMarco De Dominici, Patrizia Porazzi, Angela Rachele Soliera, et al.
Oncotarget|December 30, 2014
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphomaEnrico Derenzini, Claudio Agostinelli, Enrica Imbrogno, et al.
Respiratory Research|April 17, 2026
Quantitative computed tomography body composition analysis for risk stratification in bronchiectasisUmberto Semenzato, Virginia Santello, Giulia Fichera, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 5, 2026
Patient's features, clinical patterns and outcomes of non-tuberculous mycobacteria infections: A 10-year retrospective analysis from a third level university hospitalMaria Mazzitelli, Anna Ferrari, Giacomo Berti, et al.
BMC Bioinformatics|February 11, 2017
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing dataÍtalo Faria do Valle, Enrico Giampieri, Giorgia Simonetti, et al.
Oncotarget|July 21, 2016
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemiaAndrea Ghelli Luserna Di Rorà, Ilaria Iacobucci, Enrica Imbrogno, et al.
British Journal of Haematology|December 14, 2020
Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemiaAnna Ferrari, Andrea Ghelli Luserna Di Rora, Chiara Domizio, et al.
Pageof 16